In the medical field, botanical products usually are meant as medicines, therapeutic products, food additives, or other substances for non-essential medical use derived from plant parts or components. Starting from here, these botanical materials (e.g., plant parts, shrub roots, stems, fruits etc) or botanical products (e.g., herbal extracts, teas, oils, etc) are obtained by different methods such as… Extraction, Concentration, or Solvent extraction. This means that the materials extracted may be in the form of water, solid, semisolid, gaseous, and gas. In order to preserve the botanical product, it is mixed with other substances.
Nowadays, people are becoming more aware of the importance of botanicals as well as other natural substances in our life. This is why, people are encouraging the growth of botanical industry in the agricultural sector. In fact, many pharmaceutical companies are focusing on the development of botanical drugs and other products in order to increase the safety of the human health. Moreover, botanicals are also useful for our environment as they play an important role in the reduction of the global warming.
However, botanical drug development has undergone several challenges especially in the arena of preclinical science. These challenges include inadequate handling, transport, storage, as well as information management. Therefore, there is a need to improve the quality of botanical drug transfer process from its inception to the final stage. There are also issues of access to the botanical raw materials required and contamination of the finished product with known medicinal plants and other biological hazards. Browse through this site: etanicals.us/ if you wish to know more about botanical products.
Furthermore, many preclinical regulatory bodies have also reviewed the botanical drug products and have warned them against any potential risks. The preclinical regulatory body is formed by different countries such as the USA, UK, New Zealand, Canada, and Australia. These countries have formed a committee that reviews the reports regarding the botanical drug products and evaluate whether the product poses any risk or causes any harm. This committee helps to ensure the safety of the use of botanical compounds and ensures that the use of the botanical ingredients are consistent with the approved indications.
As per the law, only registered health claims can be filed under the name of a medicinal product. Therefore, the main aim of the regulatory authority is to protect the consumer’s right to obtain products that help in healing their illnesses. Thus, according to the Botanical Drug Application (BDA) of the US, only registered medical claims can be filed under the name of a botanical substance. This is another challenge faced by the pharmaceutical manufacturing industry. Even though many pharmaceutical products claim to contain botanical ingredients, the products that do not contain the botanical ingredients are termed as drug products and they fall under the class of food supplements. However, under the law, food supplements cannot be marketed as the botanical drugs or medicines since food supplements fall under the class of dietary supplements.
Moreover, the botanical sources alone cannot fulfill the demand for the botanicals. There are several other sources which are necessary for the efficient manufacture of the herbal medicines. Hence, botanicals form an important but neglected component of the pharmaceuticals. Hence, in the future, botanical sources will play an important role as the pharmaceutical manufacturers continue to discover the uses of botanicals. This post: https://en.wikipedia.org/wiki/Botanical_drug elaborates more on the topic, so you may need to check it out.